Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 2,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pregnancy Clear all

Conditions: Respiratory Syncytial Virus Infections
Interventions: GSK3888550A RSV Maternal vaccine formulation 1, GSK3888550A RSV Maternal vaccine formulation 2, GSK3888550A RSV Maternal vaccine formulation 3, Placebo (Normal Saline); Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 502 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Lenexa, Kansas • Rochester, New York

Conditions: Bipolar Disorder
Interventions: Lithium; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gestational Diabetes, Diabetes, Gestational, Pregnancy in Diabetes
Interventions: Insulin, Glyburide, Metformin; Drug
Lead sponsor: Maisa N. Feghali, MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pregnancy
Interventions: Continuous ambulatory subcutaneous glucose monitor; Device
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Depression
Interventions: Mindful Moms, Prenatal Education; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Maternal Outcomes, Infant Outcomes, Pregnancy
Interventions: Not listed
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 13 Years to 49 Years · Female only
Enrollment: 1,192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Newton, Massachusetts

Conditions: Maternal and Child Health Outcomes
Interventions: Vitamin A alone, Multivitamins excluding vitamin A, multivitamins including vitamin A, Placebo; Dietary Supplement · Other
Lead sponsor: Harvard School of Public Health (HSPH); Other
Eligibility: 18 Years and older · Female only
Enrollment: 771 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gestational Diabetes, Diabetes Mellitus, Type 2
Interventions: Insulin Detemir, Insulin NPH; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 336 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Fertility
Interventions: Self administration; Procedure
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Fort Myers, Florida • Tampa, Florida

Conditions: Opioid-use Disorder
Interventions: Mindfulness-Oriented Recovery Enhancement; Behavioral
Lead sponsor: University of Montana; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Missoula, Montana

Conditions: Bipolar Affective Disorders, Cyclothymic Disorder, Schizoaffective Disorder, Major Depressive Disorder, Dysthymic Disorder, Obsessive-Compulsive Disorder, Panic Disorder, Posttraumatic Stress Disorder, Premenstrual Dysphoric Disorder, Social Anxiety Disorder
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Contraception, Menorrhagia
Interventions: ESS305 (Essure, BAY1454032), NovaSure; Device · Procedure
Lead sponsor: Bayer; Industry
Eligibility: 21 Years to 50 Years · Female only
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 17
States / cities: Aurora, Colorado • Ocala, Florida • Decatur, Illinois + 14 more

Conditions: Pregnancy
Interventions: Not listed
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Pregnancy in Adolescence, Rural Health, Hispanic or Latino
Interventions: Healthy futures ("Futuros Saludables"); Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 18 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Labor Pain
Interventions: Clonidine or fentanyl; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Tobacco Use Cessation, Pregnancy Related
Interventions: SmartWatch SmokeBeat Application; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: Female only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Healthy Males
Interventions: Acyline, placebo hCG (no active ingredient), hCG (human chorionic gonadotropin), Testosterone gel; Drug · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Infections, Streptococcal, Streptococcal Infections
Interventions: GBS Vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 1,053 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 5
States / cities: Redding, California • Lenexa, Kansas • Baltimore, Maryland + 2 more

Conditions: Nicotine Dependence, Pregnancy
Interventions: Biomarker feedback (phone based smoking cessation counseling), Control condition (phone based smoking cessation counseling); Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Anchorage, Alaska

Conditions: Infertility, Female, Reproductive Techniques, Assisted, Fertilization in Vitro
Interventions: Intracytoplasmic Sperm Injection (ICSI), Conventional Insemination (IVF); Procedure
Lead sponsor: Shady Grove Fertility Reproductive Science Center; Other
Eligibility: Female only
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
Interventions: Ovarian autotransplantation; Procedure
Lead sponsor: Samuel Kim, MD; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chlorhexidine Gluconate Cloths, Infection; Cesarean Section, Infectious Morbidity, Surgical Site Infections, Endometritis
Interventions: 2% chlorhexidine gluconate (CHG) cloth, Placebo cloth; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,356 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy Weight Gain, Postpartum Weight Retention, Childhood Obesity, Gestational Diabetes, Overweight and Obesity
Interventions: Healthy for Two/Healthy for You; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 534 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Premature Labor, Pregnancy, Premature Birth
Interventions: Serial blood collection; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Birmingham, Alabama • Jackson, Mississippi • New York, New York + 3 more

Search by objective public record fields.

A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women

Lithium Therapy: Understanding Mothers, Metabolism and Mood

Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus

Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor

Mindful Moms Randomized Control Trial

Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

Vitamins, Breastmilk HIV Shedding, and Child Health

DETERMINE: Detemir vs NPH

Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate

A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder

The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels

A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test

Outpatient Cervical Ripening

Latino Teen Pregnancy Prevention K23

Epidural Fentanyl-bupivacaine Versus Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor

Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women

HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Biomarker Feedback to Motivate Cessation in Pregnancy

SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques

Human Ovarian Autotransplantation

STRIPES Study: Study To Reduce Infection Post cEsarean Section

Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity

Indomethacin PK and PD Therapy in Pregnancy